Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
376.30
Change Change %
-50.25 -11.78%

Updated:18 Jan, 2019, 14:24 PM IST

BSE
388.90
Change Change %
-38.25 -8.95%

Updated:18 Jan, 2019, 15:04 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Religare
N/A
21-03-2014 Buy 585.00 740.00
N/A
Target Hit Long (1Y)
21-03-2015

Religare maintains buy on Sun Pharma

Stock correction is overdone. Expect strong guidance by Sun post Q4. New competitor in Doxil is at least a year away. Valuations reasonable post correction. 

Top